HOP Lyon Sud

Pierre-Bénite 69495

0 studies enrolling now · 5 studies all time

What they study most

Breast Neoplasms, Cystic Fibrosis, Hemorrhage, Leukemia, Myeloid, Acute, Mesothelioma

Studies at this site

• The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread — Completed
• Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) — Completed
• A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1 — Stopped early
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed